Dabigatran etexilate

Description

Dabigatran Etexilate Mesylate is a generic prescription oral capsule medication, available in strengths of 75mg, 110mg, and 150mg (equivalent to base). Manufactured by Alembic Pharmaceuticals, it acts as a direct thrombin inhibitor to help prevent blood clots. This information was generated using AI and is provided for informational and research purposes only.

Resources

Name Format Description Link
21 Access the FDA dataset for Dabigatran etexilate — ANDA 214358 submitted by Mylan Institutional LLC https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214358

Tags

  • drug-information
  • drug-manufacturers
  • public-health
  • pharmaceuticals
  • medications

Topics

Categories